![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Prurigo Nodularis - 8 Studies Found
Completed |
: A Randomized Placebo-Controlled Study of the Neurokinin-1 (NK1) Receptor Antagonist Serlopitant Prurigo Nodularis (PN) : Prurigo Nodularis : 2014-07-14 :
|
Completed |
: Safety and Efficacy of CC-10004 for Prurigo Nodularis : Prurigo Nodularis : 2009-03-23 : Drug: CC-10004 30mg,oral medication, BID, for 24 weeks (60mg total DAILY) |
Completed |
: Effectiveness of the Selective Serotonin Reuptake Inhibitor,Citalopram (Cipralex), in Prurigo Nodularis : Prurigo Nodularis : 2007-09-19 : Drug: citalopram (cipralex) 10-20 mg/day, for 12 weeks. |
Active, not recruiting |
: Open Label Extension Study of Nalbuphine HCl ER in Patients With Prurigo Nodularis :
|
Completed |
: Evaluation of the Antipruritic Effect of Elidel (Pimecrolimus) in Non-atopic Pruritic Disease : Prurigo Nodularis : 2007-07-26 :
|
Completed |
: Study of Nalbuphine HCl ER Tablets in Patients With Prurigo Nodularis :
|
Not yet recruiting |
: Dapsone Prurigo Study : Lichen Simples Chronicus and Prurigo : 2013-06-03 : Drug: Dapsone gel - verum Other Name: aczone gel |
RECRUITING |
: A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) : Prurigo Nodularis : 2024-09-07 : Ruxolitinib cream 1.5% twice daily (BID) during the continuous and open label treatment period. |